- This event has passed.
Let’s talk about the startup F word – Finance. It’s a critical component of a company’s success, and it’s more than just spreadsheets. We’re giving this topic its day in the sun, answering such questions as… When does a startup need a CFO? What functions should a CFO serve? What qualities are desirable in a CFO? How can startups without a CFO best attend to their finances?
Join us on Tuesday, April 11th from 5:30-7:30pm at the Columbus Center (701 E Pratt Street) for this fireside-chat style event, moderated by Ken Malone of BioHealth Innovation, Inc. and Early Charm Ventures. We will hear the experiences and perspectives of Eileen O’Rourke, Chief Financial Officer at The Abell Foundation, Steve Dubin, Principal, SDA Ventures LLC; Chairman, Enzymotec Ltd., and Ryan McQueeney, Chief Financial Officer at RedOwl.
Program: 6-7pm with BioBuzz networking before and after.
Many thanks to our lead sponsor, PNC Bank.
Supporting Sponsors: Institute of Marine and Environmental Technology (IMET); Harbor Launch; BioBuzz; Early Charm Ventures LLC; BioHealth Innovation, Inc.
Chief Financial Officer at RedOwl
Ryan McQueeney joined RedOwl in August 2013 and is currently the CFO of RedOwl. In his role, he leads all aspects of finance and accounting for RedOwl, to include strategic planning, forecasting, budgeting, investor relations, and treasury. Prior to RedOwl, Ryan was the Director of Finance in Competitive Power Ventures where his responsibilities included short and long-term forecasting and budgeting, financial modeling, and treasury functions for a portfolio of assets. He also worked in various accounting and finance positions at Constellation Energy Group and brings a decade of experience in public accounting across the real estate, technology, and healthcare sectors. Ryan serves on the Board of Behavioral Health Systems Baltimore and is an advisor to exaqueo, a workforce consultancy. Ryan earned his MBA from Loyola University Maryland and a Bachelor of Science in Accounting from Virginia Tech. Ryan is the proud head coach of his twin daughter’s travel softball team.
Chief Financial Officer at The Abell Foundation
Eileen is an experienced executive with 30 years of leadership experience in finance, business management, strategic planning, and operational excellence. As Chief Financial Officer, Eileen has overall responsibilities for the business and investment operations of the Foundation. Eileen actively participates with the management team in advancing commercialization of promising technologies through deal structuring, board level review, and oversight. A manager and negotiator of direct investments in early stage companies and in program-related non-profit projects; Eileen provides innovative financing solutions to support social mission activities. Results-driven and team-oriented, she negotiates and monitors loans, guarantees and other financial arrangements in program-related non-profit projects and is also responsible for investment implementation and performance monitoring of portfolios. She graduated summa cum laude from Loyola College and is a certified public accountant, a registered securities broker, and a certified financial and operations principal. A former KPMG Manager and Vice-President with Legg Mason Inc., Eileen represents the Foundation on the board of directors of its investments in eNeura, Pixelligent, and Ceratech and on the Investment Committee of the Propel Baltimore Fund in which the Foundation is a limited partner. She is also on the board and finance committee of the Everyman Theatre.
Principal, SDA Ventures LLC; Chairman, Enzymotec Ltd.
Mr. Dubin is a Principal in SDA Ventures LLC, a firm focused on assisting emerging growth and middle-market companies, primarily in the health & wellness and nutritional products markets, on matters including corporate development, business acquisition, customer relations, growth strategies and corporate finance. Mr. Dubin is the Chairman of Enzymotec Ltd., a leading global supplier of specialty lipid-based products and solutions. Also, Mr. Dubin, in conjunction with SDA Ventures, LLC, is a Senior Advisor to Paine & Partners, LLC, a global private equity investment firm located in New York, Chicago, and San Francisco, for the purpose of working with Paine to identify and execute investment opportunities in the global human and animal food and nutritional products industries. Mr. Dubin played a key role in developing Martek Biosciences Corporation, focused on high-value products from microbial sources that promote health and wellness through nutrition, from an R&D company to a fully integrated, profitable, commercial organization with over $470 million in annual sales. He served in a variety of positions with Martek over the 14 years before his election as CEO in July 2006, including President, CFO, Treasurer, Secretary, General Counsel and Senior VP of Business Development. He also led Martek’s initial round of institutional financing in 1986. Martek was sold to Royal DSM in 2011 for close to $1.1 billion.